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Patients with co-existing hereditary spherocytosis (HS) and UDP-glucuronosyl-
transferase 1A1 (UGT1A1) deficiency as Gilbert’s syndrome (GS) have been re-
ported, and previous studies have demonstrated an increased risk for developing 
gallstones in patients with co-inheritance of GS and HS. We experienced an inter-
esting case of HS showing persistent jaundice after splenectomy, and upon further 
evaluation, the 25-year-old female patient was found to have HS combined with 
UGT1A1 deficiency. Sequence analysis of the UGT1A1 gene revealed that she was 
a compound heterozygote with p.[G71R; Y486D] + [Y486D] mutations, which 
suggests Crigler-Najjar syndrome type II rather than GS. Careful evaluation of in-
appropriately elevated bilirubin level compared with the degree of hemolysis is im-
portant, reflecting the therapeutic implication of splenectomy and cholecystectomy. 
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INTRODUCTION
Hereditary spherocytosis (HS) is the most common cause of hemolytic anemia 
due to constitutional erythrocyte membrane disorder. Most patients have well-
compensated hemolysis but have icterus and cholelithiasis due to chronic hemoly-
sis.1 Familial non-hemolytic unconjugated hyperbilirubinemia including Crigler-
Najjar syndrome type I, Crigler-Najjar syndrome type II (CN-II), and Gilbert’s 
syndrome (GS), is associated with a defect in isoenzyme 1A1 of UDP-glucuronos-
yltransferase (UGT1A1).2 Cases with co-existence of HS and UGT1A1 deficiency 
as GS have been reported,3-5 and previous studies have demonstrated an increased 
risk for developing gallstones in patients with co-inheritance of HS and GS.6,7 How-
ever, there are no reports on HS coexisting with other deficiency state of UGT1A1.
CASE REPORT
    
The patient was a 25-year-old Japanese woman who had a history of jaundice for Shigeo Iijima, et al.
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Physical examination was remarkable only for icteric sclera. 
Extensive laboratory evaluation revealed normal levels of 
liver-associated enzymes and lactate dehydrogenase 
(LDH). The haptoglobin level was 6.0 μmol/L with a total 
bilirubin of 102 and unconjugated fraction of 100 μmol/L. 
A complete blood count revealed normal numbers of white 
blood cells and platelets with a hemoglobin level of 12.4 g/
dL. The corrected reticulocyte count was 34 × 106 /L. A pe-
ripheral blood smear revealed spherocytes. Incubated os-
motic fragility was slightly increased. Sequence analysis of 
the UGT1A1 gene revealed that the patient was heterozy-
gous for a missense mutation (c.211G > A: p.G71R in exon 
1) and homozygous for a point mutation (c.1456T > G: 
p.Y486D in exon 5); that is, she was a compound heterozy-
gote with the p.[G71R; Y486D] + [Y486D] mutations (Fig. 
1). As for the parents of the patient, detailed laboratory data 
could not be obtained, and neither a molecular study of 
their UGT1A1 gene nor analysis of their erythrocyte mem-
brane proteins was performed.
DISCUSSION
According to the diagnostic criteria of HS,1 patients with no 
anemia and mild reticulocytosis are classified as having the 
mild type (hemoglobin level from 11 to 15 g/dL, reticulo-
11 years. Her family history revealed that her father had 
mild jaundice while other family members had normal se-
rum bilirubin levels. The patient received regular medical 
treatment at a psychiatric outpatient clinic because of truan-
cy. She had been referred to our hospital for extensive eval-
uation of jaundice at the age of 14 years. Her first blood ex-
amination revealed a normal hemoglobin level (12.6 g/dL), 
slightly elevated reticulocyte count (89 × 106 /L: reference 
range, 40 to 80 × 106 /L), and unconjugated hyperbilirubi-
nemia (serum total bilirubin 113 μmol/L) without elevation 
of liver-associated enzymes. A diagnosis of HS was made 
based on clinical features including chemical (haptoglobin 
< 1.0 μmol/L) and hematologic findings (spherocytes on 
blood smear and increased red cell osmotic fragility). How-
ever, biochemical analysis of the red cell membrane pro-
teins indicated no significant deficiency. Thereafter, she 
persistently demonstrated mild jaundice but not anemia. At 
the age of 16 years, she underwent splenectomy to prevent 
the formation of gallstones and to reduce skin itching which 
was probably induced by jaundice. Subsequently, the retic-
ulocyte count decreased and the serum haptoglobin level 
normalized. However, she was persistently positive for se-
rum bilirubin, which ranged between 86 and 103 μmol/L, 
and it was not clear whether her serum bilirubin level im-
proved after splenectomy. Therefore, we suspected somatic 
hyperbilirubinemia and carried out further examinations. 
Fig. 1. Nucleotide sequences of the mutated sections of exons 1 and 5 and the promoter region of the gene encoding UDP-glucurono-
syltransferase 1A1 (UGT1A1). (A) Nucleotide sequences of the mutated section of exon 1 of the UGT1A1 gene. A missense mutation at 
nucleotide 211 in exon 1 of the UGT1A1 gene is observed. The substitution of adenine for guanine changed the codon from GGA to AGA, 
causing arginine to replace glycine at position 71 (p.G71R in the corresponding protein). An arrow shows the mutation. The patient was 
heterozygous for p.G71R. (B) Nucleotide sequence of the mutated section of exon 5 of the UGT1A1 gene. The arrow shows the mutation. 
The patient was homozygous for a point mutation at base position 1456 in exon 5. The substitution of guanine for thymine changed the co-
don from TAC to GAC, causing a tyrosine-to-aspartic acid substitution at position 486 (p.Y486D in the corresponding protein).
Mutated section of exon 1 of the UGT1A1 gene
: T GT AA A A T GC T C N GT C T C T GAT GT A C A A C G
Normal ATC.AGA.GAC.GGA.GCA.TTT.TAC
              Ile      Arg      Asp     Gly     Ala     Phe     Try
Patient ATC.AGA.GAC.AGA.GCA.TTT.TAC
              Ile      Arg      Asp     Arg     Ala     Phe     Try
Normal TGG.TAG.CAG.TAC.CAT.TCC.TTG
              Thp      Tyr      Gln     Tyr     His     Ser     Leu
Patient TGG.TAC.CAG.GAC.CAT.TCC.TTG
              Thp      Tyr      Gln     Asp     His     Ser     Leu
: T G G T AC CA G G NC CA T T
155          160          165          170          175          180 105          110          115          120
3’ 3’ 5’ 5’
Mutated section of exon 5 of the UGT1A1 gene
A BHereditary Spherocytosis and Crigler-Najjar Syndrome
Yonsei Med J   http://www.eymj.org   Volume 52   Number 2   March 2011 371
develop pigment stones once the spleen is removed.19 A pa-
tient with HS who coinherited GS, has an almost 5-fold 
greater tendency to form gallstones than a normal HS pa-
tient.6 Coexistence with CN-II might further increase the 
risk of gallstone formation. Therefore, in cases of HS com-
bined with reduced hepatic bilirubin conjugation, it is un-
known whether splenectomy alone can sufficiently reduce 
hemolysis and prevent subsequent gallstone formation. 
Combined prophylactic splenectomy and cholecystectomy 
might be recommended for cases like ours. Careful evalua-
tion of inappropriately high serum bilirubin level compared 
with the degree of hemolysis as defined in the diagnostic 
criteria of HS1 is important, reflecting the therapeutic impli-
cation of splenectomy and cholecystectomy.
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